- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07939165
Trochleoplasty in the Management of Objective Patellar Instability: a Personalized Surgical Approach for the Prevention of Recurrence in Patients With Trochlear Dysplasia (TROCHLEO-CARE)
This is a multicentre, international, non-profit observational study aimed at prospectively validating a personalized diagnostic and therapeutic algorithm based on the Dejour v3.0 classification in patients with recurrent objective patellar instability and trochlear dysplasia.
The primary objective is to compare treatment failure rates at 24 months between patients with severe trochlear dysplasia (trochlear bump >5 mm) treated with trochleoplasty and MPFL reconstruction, and a retrospective control group with similar trochlear morphology treated without trochleoplasty.
Secondary outcomes include clinical and functional outcomes assessed using validated scores (IKDC, Kujala, Tegner and BPII 2.0), cartilage status assessed by MRI using the MOAKS score, and postoperative complications, particularly arthrofibrosis.
Patients aged 14-49 years will be enrolled at IRCCS Istituto Ortopedico Rizzoli and Lyon Ortho Clinic. The study includes both a prospective cohort managed according to the Dejour v3.0 algorithm and a retrospective historical control cohort. Follow-up assessments will be performed up to 24 months after surgery.
The study is planned to start on October 1, 2026, with an expected completion date of September 30, 2029. A total sample size of 152 patients (76 per group) is planned.
Přehled studie
Postavení
Typ studie
Zápis (Odhadovaný)
Kontakty a umístění
Studijní kontakt
- Jméno: Stefano Zaffagnini
- Telefonní číslo: 0516366075
- E-mail: stefano.zaffagnini@ior.it
Studijní místa
-
-
Bologna
-
Bologna, Bologna, Itálie, 40136
- IRCCS Rizzoli Orthopedic Institute
-
Kontakt:
- Stefano Zaffagnini
- Telefonní číslo: 0516366075
- E-mail: stefano.zaffagnini@ior.it
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
The study will be conducted within the facilities of the Orthopedic and Traumatology Clinic II Unit at the IRCCS Istituto Ortopedico Rizzoli and at the Lyon Ortho Clinic. Surgical procedures will be performed at both these institutions.
Patients will be asked to sign an informed consent during the hospital stay and after signing the informed consent will be asked to complete a questionnaire on the preoperative condition.
Clinical follow-up visits will be carried out at the outpatient clinics of the IRCCS Istituto Ortopedico Rizzoli as well as at the Lyon Ortho Clinic.
Popis
Inclusion Criteria study group:
- Patients aged ≥14 years and <50 years
- Male and female patients
- Patients with a clinical history of recurrent objective patellar instability (OPI)
- Provision of written informed consent to participate in the study
- Patients who performed preoperative imaging studies (MRI) that confirmed the diagnosis and the need for treatment based on the above mentioned criteria (type 3 dysplasia with a bump >5mm)
Exclusion Criteria study group:
- Patients with established knee osteoarthritis (K-L ≥2)
- Patients with concomitant ligament injuries (including anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), or collateral ligaments)
- Patients with a history of prior knee surgery for conditions other than patellar instability
- Patients who have previously undergone surgical procedures for patellar instability (OPI)
- Patients with incomplete or inadequate MRI data
Inclusion Criteria control group:
- Patients aged ≥14 years and <50 years treated for OPI with another procedure except trochleoplasty in the two reference centres from 2022 to 2024
- Male and female patients
- Provision of written informed consent to participate in the study
- Patients who performed preoperative imaging studies (MRI/CT scan) that confirmed a type 3 dysplasia with a bump >5mm
Exclusion Criteria control group:
- Patients with concomitant ligament injuries (including anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), or collateral ligaments)
- Patients with a history of prior knee surgery for conditions other than patellar instability
- Patients who have had previously undergone surgical procedures for patellar instability (OPI) at the time of the MRI/CT scan
- Patients with incomplete or inadequate MRI or CT scan data
Studijní plán
Jak je studie koncipována?
Detaily designu
- Observační modely: CASE_CONTROL
- Časové perspektivy: PROSPECTIVE
Kohorty a intervence
Skupina / kohorta |
|---|
|
Case group
Patients who performed preoperative imaging studies (MRI) that confirmed the diagnosis and the need for treatment based on the above mentioned criteria (type 3 dysplasia with a bump >5mm). They are treated according to the Dejour v3.0 algorithm, which involves trochleoplasty combined with medial patellofemoral ligament (MPFL) reconstruction. |
|
Control group
The control group includes patients with comparable anatomical characteristics who were previously treated without trochleoplasty. |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Failure rates
Časové okno: At 24 months
|
Defined as reoperation for subsequent atraumatic patellar luxation or persistent instability at 24 months. They will be registered in the CRF during the follow-up visits or during the telephonic contact in case of missing follow-ups. This could also be assessed through the clinical documentation of the patient, in case of missing data. |
At 24 months
|
Spolupracovníci a vyšetřovatelé
Sponzor
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Odhadovaný)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další identifikační čísla studie
- TROCHLEO-CARE
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .